Mckesson (MCK) Return on Capital Employed (2009 - 2026)
Mckesson (MCK) posted quarterly Return on Capital Employed of 38.25% for Q1 2026, down 18.0% year-over-year from 46.65% in Q1 2025, and up 8.57% quarter-over-quarter from 35.23% in Q4 2025.
Mckesson (MCK) Return on Capital Employed (2009 - 2026) Analysis & Trends
Mckesson (MCK) has reported Return on Capital Employed for 18 consecutive years, with 38.25% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Capital Employed fell 18.0% year-over-year to 38.25%; the TTM figure through Mar 2026 stood at 38.25% (down 18.0% YoY), while the FY2026 annual figure was 53.03%, up 738.0% from the prior year.
- Return on Capital Employed grew to 38.25% in Q1 2026 per MCK's latest filing, from 35.23% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 38.43% in Q1 2025 and bottomed at 13.55% in Q1 2022.
- Historically, Return on Capital Employed has averaged 28.62% across 5 years, with a median of 30.06% in 2023.
- Annual changes were most pronounced in 2022 — Return on Capital Employed surged 5211 bps — and 2024, when it sank 454 bps.
- Mckesson's Return on Capital Employed stood at 27.11% in 2022, then fell by 7 bps to 25.09% in 2023, then advanced by 22 bps to 30.68% in 2024, then increased by 15 bps to 35.23% in 2025, then advanced by 9 bps to 38.25% in 2026.
- Business Quant data shows MCK's Return on Capital Employed at 38.25% in Q1 2026, 35.23% in Q4 2025, and 35.76% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 102.57 Bn | 97.41 Bn | 3.69 Bn | 43.39% |
| 2 | Cencora | 61.35 Bn | 58.53 Bn | 3.61 Bn | 12.93% |
| 3 | Cardinal Health | 54.15 Bn | 49.30 Bn | 2.56 Bn | 19.96% |
| 4 | Henry Schein | 10.05 Bn | 9.89 Bn | 1.10 Bn | 8.66% |
| 5 | Akso Health | 671.90 Mn | 671.70 Mn | - | - |
| 6 | Edap Tms | 154.62 Mn | 133.07 Mn | 7.34 Mn | -74.44% |
| 7 | Accendra Health | 90.69 Mn | 83.04 Mn | 263.41 Mn | 1.84% |
| 8 | 111 | 31.31 Mn | -27.44 Mn | 18.18 Mn | -6.99% |
| 9 | Cosmos Health | 13.28 Mn | 10.84 Mn | 1.51 Mn | -67.72% |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | 0.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 43.39% |
| Mar 31, 2026 | 38.25% |
| Dec 31, 2025 | 35.23% |
| Sep 30, 2025 | 35.76% |
| Jun 30, 2025 | 31.88% |
| Mar 31, 2025 | 38.43% |
| Dec 31, 2024 | 30.68% |
| Sep 30, 2024 | 26.09% |
| Jun 30, 2024 | 29.25% |
| Mar 31, 2024 | 26.74% |
| Dec 31, 2023 | 25.09% |
| Sep 30, 2023 | 30.63% |
| Jun 30, 2023 | 30.06% |
| Mar 31, 2023 | 30.11% |
| Dec 31, 2022 | 27.11% |
| Sep 30, 2022 | 21.57% |
| Jun 30, 2022 | 16.07% |
| Mar 31, 2022 | 13.55% |
| Dec 31, 2021 | 14.91% |
| Sep 30, 2021 | -30.54% |